Tag Archives: Symbion

Upjohn Australia moves to wholesale distribution

It has been announced that from February 2020, Upjohn Australia Pty Ltd (a subsidiary of Pfizer Inc.) will distribute medicines through Community Service Obligation (CSO) pharmaceutical distributors. Upjohn announced the decision by signing a contract with Symbion, with negotiations expected to be finalised with other wholesalers shortly. According to Upjohn …

Read More »

NPSA members rally in face of fire

NPSA members have adjusted delivery schedules and seconded other resources to deliver essential medicines during the unprecedented bushfire emergency in New South Wales and Queensland. Team members at Symbion, Sigma and API warehouses along the eastern seaboard have been remapping distribution routes and working with emergency services to ensure pharmaceutical …

Read More »

Cann Group reach cannabis distribution agreement with Symbion

Cann Group Limited (Cann) is launching a range of imported medicinal cannabis products to be distributed to approved Special Access Scheme (SAS) patients by Symbion Pty Ltd. Cann’s agreement with Symbion, suppliers of healthcare services and products to more than 4000 retail pharmacies and 1300 hospitals throughout Australia, will ensure …

Read More »

AstraZeneca’s exit, a win for customers

Symbion CEO Brett Barons believes pharmacists and patients are the major beneficiaries of AstraZeneca’s decision to exit its exclusive-direct distribution arrangements. The decision means AstraZeneca will return supply of its PBS medicines through the full-line CSO wholesaler, effectively reversing the decision almost two years ago when the company moved nine …

Read More »

Symbion opens world-class distribution centre in Queensland

Symbion officially unveiled its new state-of-the-art $59 million distribution centre in Queensland this week. Incorporating the latest in automation technology, the Acacia Ridge facility operates with industry-leading accuracy and efficiency, ensuring Symbion can meet the needs of healthcare patients across Queensland well into the future. Symbion CEO Brett Barons said …

Read More »

PSA announces 2019 Excellence Award winners

Three outstanding pharmacists have been honoured for their high standards of commitment and professionalism in the 2019 PSA Excellence Awards. The Early Career Pharmacist of the Year, Pharmacist of the Year, and Lifetime Achievement Award were announced at PSA’s flagship conference PSA19 in Sydney today. PSA National President Dr Chris …

Read More »

NPSA welcomes CSO news

The National Pharmaceutical Services Association (NPSA) has welcomed the recent Federal Government announcement of the reappointment of its four member organisations to participate in the Community Service Obligation (CSO). Sigma Healthcare, Symbion, Australian Pharmaceutical Industries (API) and NPD (National Pharmacies) – have all been reappointed with new contracts that commenced …

Read More »

New Willach Country Manager

Willach Australia has appointed Meg Brideson (nee Hurley) as Country Manager for Australia and New Zealand, effective April 1. The current Willach Australia Managing Director John Koot will step down from the role on March 31, handing the day-to-day responsibility for the Australasian business to Mrs Brideson at that time. …

Read More »

Exclusive distribution ends

AstraZeneca will use a new distribution model from February 2019, claiming the new model will not cherry-pick and there will be no exclusive deals. Currently, pharmacists can order all AstraZeneca medicines via courier company DHL, and from February 1, 2019, pharmacists will also be able to order the full range …

Read More »

Exclusive distribution model ending

AstraZeneca will use a new distribution model from February 2019 claiming the new model won’t cherry-pick and there will be no exclusive distribution. Currently, pharmacists can order all AstraZeneca medicines via DHL and from 01 February 2019, pharmacists will also be able to order the full range through their preferred …

Read More »